PE20160198A1 - Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas - Google Patents

Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas

Info

Publication number
PE20160198A1
PE20160198A1 PE2016000111A PE2016000111A PE20160198A1 PE 20160198 A1 PE20160198 A1 PE 20160198A1 PE 2016000111 A PE2016000111 A PE 2016000111A PE 2016000111 A PE2016000111 A PE 2016000111A PE 20160198 A1 PE20160198 A1 PE 20160198A1
Authority
PE
Peru
Prior art keywords
treatment
methods
topical compositions
excessive sweating
water
Prior art date
Application number
PE2016000111A
Other languages
English (en)
Inventor
Elizabeth K Hussey
Maria Graziella Larm
Jon Lenn
Virginia D Schmith
Michael R Luke
Teodora X Pene-Dumitrescu
Leandro L Santos
Leon Loupenok
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51626097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20160198(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of PE20160198A1 publication Critical patent/PE20160198A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA PARA ADMINISTRACION TOPICA QUE COMPRENDE: A) UNA CANTIDAD DE 0.5% A 5% EN PESO DE 4-[HIDROXI(DIFENIL)METIL]-1-{2-[(FENILMETIL)OXI]ETIL}-1-AZONIABICICLO[2.2.2]OCTANO (UMECLIDINIO) Y UN ANION FARMACEUTICAMENTE ACEPTABLE DEL MISMO TAL COMO CLORURO, BROMURO, YODURO, ENTRE OTROS; Y B) UN SOLVENTE QUE COMPRENDE UNA MEZCLA DE AGUA Y UN SOLVENTE ORGANICO MISCIBLE EN AGUA. DICHO COMPUESTO ES UN ANTAGONISTA MUSCARINICO PAN-ACTIVO DE LARGA DURACION SIENDO UTIL PARA EL TRATAMIENTO DE HIPERHIDROSIS O SUDOR EXCESIVO
PE2016000111A 2013-07-30 2014-07-30 Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas PE20160198A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361859947P 2013-07-30 2013-07-30
US201461952238P 2014-03-13 2014-03-13
US201462021878P 2014-07-08 2014-07-08

Publications (1)

Publication Number Publication Date
PE20160198A1 true PE20160198A1 (es) 2016-04-21

Family

ID=51626097

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016000111A PE20160198A1 (es) 2013-07-30 2014-07-30 Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas

Country Status (17)

Country Link
US (2) US20150037269A1 (es)
EP (1) EP3027184A1 (es)
JP (1) JP2016525569A (es)
KR (1) KR20160034920A (es)
CN (1) CN105555269A (es)
AU (1) AU2014297993A1 (es)
BR (1) BR112016001696A2 (es)
CA (1) CA2919979A1 (es)
CR (1) CR20160055A (es)
EA (1) EA201690302A1 (es)
HK (1) HK1225317A1 (es)
IL (1) IL243681A0 (es)
MX (1) MX2016001465A (es)
PE (1) PE20160198A1 (es)
PH (1) PH12016500096A1 (es)
SG (1) SG11201600045UA (es)
WO (1) WO2015015446A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015275933A1 (en) 2014-06-18 2017-02-02 Cipla Limited Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
AU2016297601B2 (en) 2015-07-21 2021-08-19 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
WO2019072877A1 (en) * 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
JP2022554264A (ja) * 2019-11-05 2022-12-28 ジャーニー メディカル コーポレーション 医薬組成物の手掌又は足底投与のための方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4885282A (en) 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US8980290B2 (en) * 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20040192754A1 (en) 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
PT1729821E (pt) 2004-03-03 2013-10-23 Revance Therapeutics Inc Composições e métodos para aplicação tópica e administração transdérmica de toxinas botulínicas
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
ES2671874T3 (es) * 2007-10-18 2018-06-11 Rose U, Llc Formulaciones tópicas de glicopirrolato
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
AU2013365742B2 (en) * 2012-12-19 2016-11-24 Novartis Ag Autotaxin inhibitors

Also Published As

Publication number Publication date
BR112016001696A2 (pt) 2017-08-01
KR20160034920A (ko) 2016-03-30
CR20160055A (es) 2016-04-04
WO2015015446A1 (en) 2015-02-05
EP3027184A1 (en) 2016-06-08
CN105555269A (zh) 2016-05-04
IL243681A0 (en) 2016-04-21
US20150037269A1 (en) 2015-02-05
JP2016525569A (ja) 2016-08-25
US20160166487A1 (en) 2016-06-16
AU2014297993A1 (en) 2016-02-04
CA2919979A1 (en) 2015-02-05
SG11201600045UA (en) 2016-02-26
MX2016001465A (es) 2016-06-02
HK1225317A1 (zh) 2017-09-08
EA201690302A1 (ru) 2016-06-30
PH12016500096A1 (en) 2016-04-18

Similar Documents

Publication Publication Date Title
AR090456A1 (es) Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos
AR117001A2 (es) Formulación de premezcla de dexmedetomidina
PE20160198A1 (es) Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas
CO6690768A2 (es) Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7
CU20150014A7 (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
PE20171241A1 (es) Terapias de combinacion para el tratamiento de canceres
CU20150163A7 (es) DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
AR083879A1 (es) Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos
PE20120713A1 (es) Composiciones sublinguales de dexmedetomidina y metodos para su uso
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
IN2014MN02598A (es)
AR091039A1 (es) Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento
PE20140936A1 (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
EA201690247A1 (ru) Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
ECSP15013883A (es) Benzamidas
PE20200698A1 (es) Gel que comprende clorhexidina
AR101674A1 (es) Uso de un compuesto tricíclico que contiene nitrógeno
CO2018001700A2 (es) Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismos
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
MX2018002006A (es) Benzamidas apareadas novedosas.
DOP2016000007A (es) Pirazolpiridinas sustituidas

Legal Events

Date Code Title Description
FD Application declared void or lapsed